X
API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
83
PharmaCompass offers a list of Clazosentan Sodium API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Clazosentan Sodium manufacturer or Clazosentan Sodium supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Clazosentan Sodium manufacturer or Clazosentan Sodium supplier.
PharmaCompass also assists you with knowing the Clazosentan Sodium API Price utilized in the formulation of products. Clazosentan Sodium API Price is not always fixed or binding as the Clazosentan Sodium Price is obtained through a variety of data sources. The Clazosentan Sodium Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Clazosentan Sodium manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Clazosentan Sodium, including repackagers and relabelers. The FDA regulates Clazosentan Sodium manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Clazosentan Sodium API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Clazosentan Sodium supplier is an individual or a company that provides Clazosentan Sodium active pharmaceutical ingredient (API) or Clazosentan Sodium finished formulations upon request. The Clazosentan Sodium suppliers may include Clazosentan Sodium API manufacturers, exporters, distributors and traders.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Clazosentan Sodium Drug Master File in Korea (Clazosentan Sodium KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Clazosentan Sodium. The MFDS reviews the Clazosentan Sodium KDMF as part of the drug registration process and uses the information provided in the Clazosentan Sodium KDMF to evaluate the safety and efficacy of the drug.
After submitting a Clazosentan Sodium KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Clazosentan Sodium API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Clazosentan Sodium suppliers with KDMF on PharmaCompass.
Clazosentan Sodium Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Clazosentan Sodium GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Clazosentan Sodium GMP manufacturer or Clazosentan Sodium GMP API supplier for your needs.
A Clazosentan Sodium CoA (Certificate of Analysis) is a formal document that attests to Clazosentan Sodium's compliance with Clazosentan Sodium specifications and serves as a tool for batch-level quality control.
Clazosentan Sodium CoA mostly includes findings from lab analyses of a specific batch. For each Clazosentan Sodium CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Clazosentan Sodium may be tested according to a variety of international standards, such as European Pharmacopoeia (Clazosentan Sodium EP), Clazosentan Sodium JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Clazosentan Sodium USP).
Market Place
